Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
EVO: Evotec SE Stock Analysis | finqOS
Healthcare · Drug Manufacturers - Specialty & Generic
The Story
EVO
The Story
EVO
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+2.0% / yr
Operating margin
-13.9%
ROIC
-7.9%
Financially safe
Stretched
Debt / equity
0.55×
Interest coverage
-7.1×
Current ratio
1.68×
Evotec SE
EVO
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Evotec SE
EVO
NASDAQ
·
USD
·
Closed
$1.91
−1.04%
$1.91
−$0.02 (1.04%)
52W Range
1th
pctl
Volume
0.66×
avg
Mkt Cap
678.51M
USD
P/E
-3.1
TTM
Div Yield
–
ann
52W Range
1th
pctl
Volume
0.66×
avg
Market Cap
678.51M
USD
P/E Ratio
-3.1
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings